Skip to content
Search

Latest Stories

Second wave? UK tightens lockdown in northern England

Government has imposed a tougher lockdown in swathes of northern England after a rise in the rate of novel coronavirus transmission, raising concerns that a second wave of the deadly virus could sow yet more turmoil.

Meanwhile, UK reported its highest number of new Covid-19 infections in more than a month on Thursday (July 30), as ministers fretted about a second wave of cases in Europe and warned more quarantine restrictions were possible.


Around 4 million people were ordered not to mix with other households in Greater Manchester, the biggest city in northern England, parts of West Yorkshire and East Lancashire, though they can still go to the pub and to work.

“The problem with this virus is that it thrives on the social contact which makes life worth living,” Health Secretary Matt Hancock told Sky. “I totally understand the human impact of this but unfortunately that is how the virus passes on.”

“We can see that second wave in Europe,” Hancock said.

Asked by the BBC if the UK was now entering a second wave, Hancock said: “It is not yet and we are absolutely determined to take the action that is needed.”

The measures were introduced hastily at the start of the annual Muslim Eid al-Adha “feast of sacrifice”.

People in the areas affected were told not to socialise with other households at home or in gardens, or to meet with other households in pubs, restaurants, cafes, shops, places of worship or leisure venues.

But people are allowed to attend a pub, church or mosque with members of their own household. Those breaking the rules will face a fine of 100 pounds.

Official data showed 846 new positive tests in Britain - the highest number of daily infections since June 28. (Reuters)

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less